Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.390
-0.030 (-2.11%)
At close: Nov 20, 2024, 4:00 PM
1.430
+0.040 (2.88%)
After-hours: Nov 20, 2024, 5:41 PM EST
Actinium Pharmaceuticals Stock Forecast
ATNM's stock price has decreased by -69.04% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ATNM stock have an average target of 10.2, with a low estimate of 4.00 and a high estimate of 21. The average target predicts an increase of 633.81% from the current stock price of 1.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ATNM stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $5 | Buy | Reiterates | $5 | +259.71% | Nov 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +187.77% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $4 | Strong Buy | Maintains | $50 → $4 | +187.77% | Aug 6, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $30 → $5 | Strong Buy | Maintains | $30 → $5 | +259.71% | Aug 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +3,497.12% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
231.74K
from 81.00K
Increased by 186.10%
Revenue Next Year
44.84M
from 231.74K
Increased by 19,248.94%
EPS This Year
-1.36
from -1.83
EPS Next Year
-0.71
from -1.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.2M | 61.1M | 93.2M | ||
| Avg | 231,744 | 44.8M | 90.6M | ||
| Low | n/a | 34.3M | 87.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1,372.8% | 26,261.8% | 107.9% | ||
| Avg | 186.1% | 19,248.9% | 102.0% | ||
| Low | - | 14,700.8% | 94.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.20 | 0.08 | -1.00 | ||
| Avg | -1.36 | -0.71 | -1.19 | ||
| Low | -1.62 | -1.35 | -1.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.